Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer.

MLA

Gomez, Roca, Carlos, et al. “Exploratory Window‐of‐opportunity Trial to Investigate the Tumor Pharmacokinetics/Pharmacodynamics of the IAP Antagonist Debio 1143 in Patients with Head and Neck Cancer.” CTS: Clinical & Translational Science, vol. 15, no. 1, Jan. 2022, pp. 55–62. EBSCOhost, https://doi.org/10.1111/cts.13002.

APA

Gomez, R. C., Even, C., Le Tourneau, C., Basté, N., Delord, J., Sarini, J., Vergez, S., Temam, S., Hoffmann, C., Rochaix, P., Borcoman, E., Gavillet, B., Rouits, E., Ménétrey, A., Brichory, F., Purcea, D., Vuagniaux, G., & Zanna, C. (2022). Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer. CTS: Clinical & Translational Science, 15(1), 55–62. https://doi.org/10.1111/cts.13002

Chicago

Gomez, Roca, Carlos, Caroline Even, Christophe Le Tourneau, Neus Basté, Jean‐Pierre Delord, Jerome Sarini, Sebastien Vergez, et al. 2022. “Exploratory Window‐of‐opportunity Trial to Investigate the Tumor Pharmacokinetics/Pharmacodynamics of the IAP Antagonist Debio 1143 in Patients with Head and Neck Cancer.” CTS: Clinical & Translational Science 15 (1): 55–62. doi:10.1111/cts.13002.